Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present ABIOMED, Inc. (NASDAQ: ABMD).

Full DD Report for ABMD

You must become a subscriber to view this report.


Recent News from (NASDAQ: ABMD)

Abiomed Continues To Be An Attractive Investment In 2018
I have always been an admirer of Abiomed ( ABMD ) and have explained my hypothesis for liking this stock in this article and also this article . My admiration for the company has grown even more, after I went through its latest earnings released on November 1. Abiomed has reported revenue...
Source: SeekingAlpha
Date: November, 02 2018 17:51
Abiomed to Present at the Stephens 2018 Investment Conference in New York, NY
DANVERS, Mass., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will hold a fireside chat at the Stephens NY Investment Con...
Source: GlobeNewswire
Date: November, 02 2018 08:00
Today's Research Reports on Trending Tickers: Tandem Diabetes Care, Inc. and ABIOMED, Inc.
NEW YORK, NY / ACCESSWIRE / November 2, 2018 / U.S. markets rallied on Thursday, with the S&P 500 Index logging its first 3-day win streak in six weeks, as trade concerns between the U.S. and China continued to ease. The Dow Jones Industrial Average gained 1.06 percent to close at 25,380...
Source: ACCESSWIRE IA
Date: November, 02 2018 08:00
JPMorgan and Barclays bearish on Puma in premarket healthcare analyst action
Abiomed (NASDAQ: ABMD ) upgraded to Buy with a $450 (19% upside) price target at BTIG Research after yesterday's fiscal Q2 beat. Shares up a fraction premarket. More news on: ABIOMED, Inc., Emergent BioSolutions Inc., Adverum Biotechnologies, Inc., Healthcare stocks news, Stocks on the mov...
Source: SeekingAlpha
Date: November, 02 2018 07:59
ABIOMED (ABMD) Q2 2019 Results - Earnings Call Transcript
ABIOMED, Inc. (ABMD) Q2 2019 Earnings Call November 01, 2018 8:00 am ET Executives Ingrid Goldberg - ABIOMED, Inc. Michael R. Minogue - ABIOMED, Inc. Todd A. Trapp - ABIOMED, Inc. Analysts Chris Pasquale - Guggenheim Securities LLC Jayson T. Bedford - Raymond James & ...
Source: SeekingAlpha
Date: November, 01 2018 13:16
ABIOMED, Inc. 2018 Q2 - Results - Earnings Call Slides
The following slide deck was published by ABIOMED, Inc. in conjunction with their 2018 Q2 earnings Read more ...
Source: SeekingAlpha
Date: November, 01 2018 11:42
Abiomed beats by $0.08, beats on revenue
Abiomed (NASDAQ: ABMD ): Q2 Non-GAAP EPS of $0.81 beats by $0.08 ; GAAP EPS of $1.09 beats by $0.36 . More news on: ABIOMED, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: November, 01 2018 07:14
Abiomed Announces Q2 FY 2019 Record Revenue of $182 Million, up 37% Over Prior Year
DANVERS, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart recovery and support technologies, today reported second quarter fiscal 2019 revenue of $181.8 million, an increase of 37% compared to revenue of $132.8 million for the ...
Source: Thomson Reuters ONE
Date: November, 01 2018 07:00
Notable earnings before Thursday's open
AAON , AAWW , ABMD , AGIO , ALE , AMAG , AMCX , AME , AMRN , ARES , AROC , ARW , AVP , AYR , BCE , BID , BLL , BMCH , BSIG , CBRE , CCOI , CEIX , CHD , CHSP , CI , CJ , CNQ , CNSL , CWT , D , DM , DNOW , DWDP , EEX , EGRX , EPAM , EXC , EXLS , FLWS , F...
Source: SeekingAlpha
Date: October, 31 2018 17:30
Abiomed continues slide, down 8%
ABIOMED ( ABMD -7.7% ) is down in early trade. Shares have lost  30%  of their value since touching $459.75 on October 1. No particular news accounts for the action. More news on: ABIOMED, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Source: SeekingAlpha
Date: October, 25 2018 10:11

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-08378.44377.49388.93375.2853379,843
2018-05-17380.35379.94384.40377.75535,694
2017-06-20146.24144.46147.45144.13245,271
2017-06-19144.17145.94146.32143.85175,870
2017-06-16142.75143.39143.49142.14293,856

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1847,45496,20349.3269Short
2018-12-1750,593158,93331.8329Cover
2018-12-1427,96756,35149.6300Short
2018-12-1327,09860,77444.5881Short
2018-12-1226,96775,01535.9488Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ABMD.


About ABIOMED, Inc. (NASDAQ: ABMD)

Logo for ABIOMED, Inc. (NASDAQ: ABMD)

Not available

 

Contact Information

 

 

Current Management

  • David M. Lederman / President, CEO
  • John F. Thero / CFO

Current Share Structure

  • Market Cap: $16,633,850,518 - 05/14/2018
  • Issue and Outstanding: 44,277,825 - 01/31/2018

 


Recent Filings from (NASDAQ: ABMD)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 03 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 25 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 04 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 08 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 27 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 14 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 08 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 08 2018

 

 


Daily Technical Chart for (NASDAQ: ABMD)

Daily Technical Chart for (NASDAQ: ABMD)


Stay tuned for daily updates and more on (NASDAQ: ABMD)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: ABMD)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ABMD is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of ABMD and does not buy, sell, or trade any shares of ABMD. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/